(19)

(11)

EP 4 823 545 A1

(12)

(43) Date of publication: 21.10.2026 Bulletin 2026/43 (21) Application number: 24838108.9 (22) Date of filing: 10.12.2024

(51) International Patent Classification (IPC):  A61K 9/00(2006.01) A61K 47/10(2017.01) A61P 31/00(2006.01) A61K 47/38(2006.01) A61K 9/19(2006.01) A61K 31/00(2006.01) A61K 47/26(2006.01) A61K 47/32(2006.01) A61K 9/10(2006.01) (52) Cooperative Patent Classification (CPC): A61K 9/0019; A61K 47/10; A61K 47/32; A61K 47/38; A61K 47/26; A61P 31/00; A61K 9/10; A61K 9/19; A61K 31/4985; A61K 31/77   C-Sets: A61K 31/77, A61K 2300/00; (86) International application number: PCT/US2024/059277 (87) International publication number: WO 2025/128498 (19.06.2025 Gazette 2025/25)

(84) Designated Contracting States: AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR Designated Extension States: BA Designated Validation States: GE KH MA MD TN (30) Priority: 12.12.2023 US 202363608896 P (71) Applicant: ViiV Healthcare UK (No.7) Limited Stevenage, SG1 2NY (GB)	(72) Inventors: ALIDORI, Simone Collegeville, PA 19426 (US) BHUGRA, Chandan Collegeville, PA 19426 (US) FIGUEROA, Karina Collegeville, PA 19426 (US) PAN, Rennan Collegeville, PA 19426 (US) (74) Representative: Coggins, Julia Frances  GSK Legal & Compliance - Global Patents 79 New Oxford Street London WC1A 1DG London WC1A 1DG (GB)